August 30, 2007

Takeda Pharmaceutical Company Limited

Notice of Execution of Acquisition of the Company's Own Shares

Osaka, Japan, August 30, 2007 --- Takeda Pharmaceutical Company Limited (“Takeda”) announced today that it completed acquisition of its own shares in the market, which was resolved by its Board of Directors on July 31, 2007.

1. Class of shares acquired:	Shares of common stock
2. Period of acquisition:	From August 1, 2007 to August 28, 2007
3. Total number of shared acquired:	12,865,400 shares
4. Total value of acquisition:	Yen 99,999,289,000
5. Method of acquisition:	Purchased on the Tokyo Stock Exchange

(Reference)

Resolution of the Board of Directors on July 31, 2007

1. Class of shares to be acquired:	Shares of common stock
2. Number of shares to be acquired:	Up to 13 million shares
	(equivalent to 1.46% of a total of issued shares)
3. Total amount of shares to be acquired:	Up to 100 billion Yen
4. Schedule of acquisition:	From August 1, 2007 to September 20, 2007

# # #